-
Company Insights
New![]()
Innovation and Patenting activity of Maxim Integrated Products Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Maxim Integrated Products Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (bempedoic acid + ezetimibe) in Cardiovascular Risk Factors
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (bempedoic acid + ezetimibe) in Cardiovascular Risk Factors Drug Details: Bempedoic Acid and Ezetimibe (Nexlizet/...
-
Product Insights
New![]()
Buffalo Atlee Wind Farm
Buffalo Atlee Wind Farm is an Onshore Wind project located in Alberta, Canada. The project is owned by Capstone Infrastructure Corp and is developed by Capstone Infrastructure Corp; Maxim Power Corp. The project is currently under construction. Empower your strategies with our Buffalo Atlee Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
New![]()
HR Milner 2 (M2) Combined Cycle Power Plant
HR Milner 2 (M2) Combined Cycle Power Plant is a thermal project located in Alberta, Canada. The project is owned and developed by Maxim Power Corp. The project came online in 2020. Empower your strategies with our HR Milner 2 (M2) Combined Cycle Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Inclisiran in Homozygous Familial Hypercholesterolemia (HoFH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Inclisiran in Homozygous Familial Hypercholesterolemia (HoFH) Drug Details: Inclisiran (Leqvio, Sybrava) is a cholesterol-lowering agent....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Inclisiran in Coronary Artery Disease (CAD) (Ischemic Heart Disease)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Inclisiran in Coronary Artery Disease (CAD) (Ischemic Heart Disease) Drug Details: Inclisiran (Leqvio, Sybrava) is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Alirocumab in Septic Shock
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Alirocumab in Septic Shock Drug Details: Alirocumab (REGN-727, Praluent, SAR236553, Golyra, Praluent Pen, Eliriduc)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Evolocumab in Hypercholesterolemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Evolocumab in HypercholesterolemiaDrug Details: Evolocumab (AMG-145, Repatha) is a monoclonal antibody acts as lipid modifying agent....
-
Product Insights
![]()
Cardiac Markers Rapid Tests and POC Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac Markers Rapid Tests and Point of Care (POC) are rapid diagnostic tests that are simple to perform, ready to use, accurate, economical, and for infield use suggested for individuals suspected with any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides comprehensive information about the Cardiac Markers Rapid Tests and POC pipeline products with a comparative analysis of the products at various stages of development...
-
Product Insights
![]()
MAXIM – Residensi Maxim Risen – Kuala Lumpur
Equip yourself with the essential tools needed to make informed and profitable decisions with our MAXIM - Residensi Maxim Risen - Kuala Lumpur report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Thematic Analysis
New![]()
Digital Transformation and Emerging Technologies in the Healthcare Industry – Thematic Intelligence
Explore trends and insights from the following data in our ‘Digital Transformation and Emerging Technologies in the Healthcare Industry’ report: Stay up to date on the scope, challenges, and essentials for the digital transformation within the healthcare industry. Explore how innovations are transforming the healthcare industry and what impact on the sector these technologies will have soon. Develop and design your corporate strategies through an in-house expert analysis of the key factors of digital transformation and emerging technology in the healthcare sector....
-
Sector Analysis
![]()
Spain Minimally Invasive Neurosurgery Procedures Forecast to 2030
Spain Minimally Invasive Neurosurgery Procedures Market Report Overview The total number of Minimally Invasive Neurosurgery Procedures performed in Spain was 1,123 in 2022. These procedures comprise neurosurgical devices that are used to maximize visualization of anatomy inside the brain and spinal cord during such surgery that requires minimal disruption of the body’s tissues. Spain Minimally Invasive Neurosurgery Procedures Market Outlook, 2022-2030 (Number of Procedures) Buy Full Report for More Insights on the Spain Minimally Invasive Neurosurgery Procedures Market Forecast Download...
-
Sector Analysis
![]()
Japan Minimally Invasive Neurosurgery Procedures Forecast to 2030
Japan Minimally Invasive Neurosurgery Procedures Market Report Overview The total number of Minimally Invasive Neurosurgery Procedures performed in Japan was 3,631 in 2022. These procedures comprise neurosurgical devices that are used to maximize visualization of anatomy inside the brain and spinal cord during such surgery that requires minimal disruption of the body’s tissues. Japan Minimally Invasive Neurosurgery Procedures Market Outlook, 2022-2030 (Number of Procedures) Buy Full Report for More Insights on the Japan Minimally Invasive Neurosurgery Procedures Market Forecast Download...
-
Sector Analysis
![]()
Mexico Minimally Invasive Neurosurgery Procedures Forecast to 2030
Mexico Minimally Invasive Neurosurgery Procedures Market Report Overview The total number of Minimally Invasive Neurosurgery Procedures performed in Mexico was 1,917 in 2022. These procedures comprise neurosurgical devices that are used to maximize visualization of anatomy inside the brain and spinal cord during such surgery that requires minimal disruption of the body’s tissues. Mexico Minimally Invasive Neurosurgery Procedures Market Outlook, 2022-2030 (Number of Procedures) Buy Full Report for More Insights on the Mexico Minimally Invasive Neurosurgery Procedures Market Forecast Download...
-
Sector Analysis
![]()
Russia Minimally Invasive Neurosurgery Procedures Forecast to 2030
Russia Minimally Invasive Neurosurgery Procedures Market Report Overview The total number of Minimally Invasive Neurosurgery Procedures performed in Russia was 2,369 in 2022. These procedures comprise neurosurgical devices that are used to maximize visualization of anatomy inside the brain and spinal cord during such surgery that requires minimal disruption of the body’s tissues. Russia Minimally Invasive Neurosurgery Procedures Market Outlook, 2022-2030 (Number of Procedures) Buy Full Report for More Insights on the Russia Minimally Invasive Neurosurgery Procedures Market Forecast Download...
-
Sector Analysis
![]()
South Korea Minimally Invasive Neurosurgery Procedures Forecast to 2030
South Korea Minimally Invasive Neurosurgery Procedures Market Report Overview The total number of Minimally Invasive Neurosurgery Procedures performed in South Korea was 1,549 in 2022. These procedures comprise neurosurgical devices that are used to maximize visualization of anatomy inside the brain and spinal cord during such surgery that requires minimal disruption of the body’s tissues. South Korea Minimally Invasive Neurosurgery Procedures Market Outlook, 2022-2030 (Number of Procedures) Buy Full Report for More Insights on the South Korea Minimally Invasive Neurosurgery...
-
Sector Analysis
![]()
United Kingdom (UK) Minimally Invasive Neurosurgery Procedures Count and Forecast to 2030
The United Kingdom (UK) Minimally Invasive Neurosurgery Procedures Market Report Overview The total count of minimally invasive neurosurgery procedures performed in the United Kingdom (UK) was 1,935 in 2022. Minimally invasive neurosurgical procedures comprise of neurosurgical devices that are used to maximize visualization of anatomy inside the brain and spinal cord during surgery that requires minimal disruption of the body’s tissues. The UK Minimally Invasive Neurosurgery Procedures Market Outlook 2022-2030 (Number of Procedures) Buy the Full Report for Additional Insights...
-
Sector Analysis
![]()
United States (US) Minimally Invasive Neurosurgery Procedures Count and Forecast to 2030
United States (US) Minimally Invasive Neurosurgery Procedures Market Report Overview The total number of minimally invasive neurosurgery procedures performed in the US was 52,949 in 2022. Minimally invasive neurosurgical procedures comprise of neurosurgical devices that are used to maximize visualization of anatomy inside the brain and spinal cord during surgery that requires minimal disruption of the body’s tissues. The United States (US) Minimally Invasive Neurosurgery Procedures Market Outlook 2022-2030 (Number of Procedures) Buy the Full Report for More Insights About...
-
Sector Analysis
![]()
North America Minimally Invasive Neurosurgery Procedures Count and Forecast to 2030
North America Minimally Invasive Neurosurgery Procedures Market Report Overview The total number of Minimally Invasive Neurosurgery Procedures performed in North America was 57,112 in 2022. Such procedures comprise neurosurgical devices used to maximize visualization of anatomy inside the brain and spinal cord during surgery that requires minimal disruption of the body’s tissues. North America Minimally Invasive Neurosurgery Procedures Market Outlook, 2022-2030 (Number of Procedures) Buy Full Report for More Insights on the North America Minimally Invasive Neurosurgery Procedures Market Forecast...
-
Sector Analysis
![]()
BRIC Minimally Invasive Neurosurgery Procedures Count and Forecast to 2030
BRIC Minimally Invasive Neurosurgery Procedures Market Report Overview The total number of Minimally Invasive Neurosurgery Procedures performed in BRIC was 15,963 in 2022. These procedures comprise neurosurgical devices that are used to maximize visualization of anatomy inside the brain and spinal cord during such surgery that requires minimal disruption of the body’s tissues. BRIC Minimally Invasive Neurosurgery Procedures Market Outlook, 2022-2030 (Number of Procedures) Buy Full Report for More Insights on the BRIC Minimally Invasive Neurosurgery Procedures Market Forecast Download...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.